The cross-talk between CXCR4/CXCL12 pathway and TGF-β signaling inhibited the E-cadherin expression and activated the EMT pathway, enhancing the ability of tumor invasiveness in HCC cells [57, 58]. The gene discussed is CXCR4; the disease is hepatocellular carcinoma.